Literature DB >> 16965330

Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: novel AIRE mutations and an estimate of disease prevalence.

B Stolarski1, E Pronicka, L Korniszewski, A Pollak, G Kostrzewa, E Rowińska, P Włodarski, A Skórka, M Gremida, P Krajewski, R Ploski.   

Abstract

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is an autosomal-recessive autoimmune disease caused by autoimmune regulator gene mutations. The aim of this study was to examine the mutation profile of Polish APECED patients, determine the carrier rate of the most frequent mutation(s) and estimate disease prevalence. While studying 14 unrelated patients, we identified three novel mutations (c.1A>T, affecting the start codon; [IVS1 + 1G>C; IVS1 + 5delG], a complex mutation affecting splice site; c. 908G>C, p.R303P, a missense mutation in plant homeodomain (PHD) and three previously reported mutations (c.769C>T, p.R257X; c.967_979del13bp, C322fsX372; c.931delT, p.C311fsX376). Eleven patients had mutations on both chromosomes, whereas in three patients only a single alteration with proven or likely pathogenic effect was detected. The most frequent was the p.R257X mutation (71% of chromosomes); its carriage rate was assessed in the background population. Analysis of 2008 samples showed eight heterozygotes, indicating the frequency of 0.40% (1:250) and the disease prevalence - 1:129,000 (95% confidence interval: 1:555,000 to 1:30,000). Comparison with an epidemiological estimate (1:619,000, derived for women) suggested that in Poland, APECED is underdiagnosed. Among the patients, no genotype/phenotype correlations were found, but we noted that women had earlier onset of hypoparathyroidism (p < 0.02) and were younger at diagnosis (p < 0.05) than men.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965330     DOI: 10.1111/j.1399-0004.2006.00690.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  26 in total

1.  High intrafamilial variability in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a case study.

Authors:  D Capalbo; A Fusco; G Aloj; N Improda; L Vitiello; U Dianzani; C Betterle; M Salerno; C Pignata
Journal:  J Endocrinol Invest       Date:  2011-11-07       Impact factor: 4.256

2.  Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance.

Authors:  Elise M N Ferré; Timothy J Break; Peter D Burbelo; Michael Allgäuer; David E Kleiner; Dakai Jin; Ziyue Xu; Les R Folio; Daniel J Mollura; Muthulekha Swamydas; Wenjuan Gu; Sally Hunsberger; Chyi-Chia R Lee; Anamaria Bondici; Kevin W Hoffman; Jean K Lim; Kerry Dobbs; Julie E Niemela; Thomas A Fleisher; Amy P Hsu; Laquita N Snow; Dirk N Darnell; Samar Ojaimi; Megan A Cooper; Martin Bozzola; Gary I Kleiner; Juan C Martinez; Robin R Deterding; Douglas B Kuhns; Theo Heller; Karen K Winer; Arun Rajan; Steven M Holland; Luigi D Notarangelo; Kevin P Fennelly; Kenneth N Olivier; Michail S Lionakis
Journal:  Sci Transl Med       Date:  2019-06-05       Impact factor: 17.956

Review 3.  Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Gregory M Constantine; Michail S Lionakis
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

4.  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Choudhary Sonal; McLeod Michael; Torchia Daniele; Romanelli Paolo
Journal:  J Clin Aesthet Dermatol       Date:  2012-12

5.  Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Elise M N Ferre; Stacey R Rose; Sergio D Rosenzweig; Peter D Burbelo; Kimberly R Romito; Julie E Niemela; Lindsey B Rosen; Timothy J Break; Wenjuan Gu; Sally Hunsberger; Sarah K Browne; Amy P Hsu; Shakuntala Rampertaap; Muthulekha Swamydas; Amanda L Collar; Heidi H Kong; Chyi-Chia Richard Lee; David Chascsa; Thomas Simcox; Angela Pham; Anamaria Bondici; Mukil Natarajan; Joseph Monsale; David E Kleiner; Martha Quezado; Ilias Alevizos; Niki M Moutsopoulos; Lynne Yockey; Cathleen Frein; Ariane Soldatos; Katherine R Calvo; Jennifer Adjemian; Morgan N Similuk; David M Lang; Kelly D Stone; Gulbu Uzel; Jeffrey B Kopp; Rachel J Bishop; Steven M Holland; Kenneth N Olivier; Thomas A Fleisher; Theo Heller; Karen K Winer; Michail S Lionakis
Journal:  JCI Insight       Date:  2016-08-18

Review 6.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.

Authors:  Kai Kisand; Pärt Peterson
Journal:  J Clin Immunol       Date:  2015-07-05       Impact factor: 8.317

7.  Molecular background and genotype-phenotype correlation in autoimmune-polyendocrinopathy-candidiasis-ectodermal-distrophy patients from Campania and in their relatives.

Authors:  D Capalbo; C Mazza; R Giordano; N Improda; E Arvat; S Cervato; L Morlin; C Pignata; C Betterle; M Salerno
Journal:  J Endocrinol Invest       Date:  2011-04-20       Impact factor: 4.256

Review 8.  PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks.

Authors:  Lindsey A Baker; C David Allis; Gang G Wang
Journal:  Mutat Res       Date:  2008-07-17       Impact factor: 2.433

Review 9.  PHD fingers: epigenetic effectors and potential drug targets.

Authors:  Catherine A Musselman; Tatiana G Kutateladze
Journal:  Mol Interv       Date:  2009-12

Review 10.  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy from the pediatric perspective.

Authors:  D Capalbo; N Improda; A Esposito; L De Martino; F Barbieri; C Betterle; C Pignata; M Salerno
Journal:  J Endocrinol Invest       Date:  2013-05-30       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.